To facilitate the sale and address its debt obligations, Synergy initiated voluntary proceedings under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Southern District of New York. Such statements speak only as of the date hereof and are subject to change. Additional information about Synergy's Chapter 11 cases can be found at https://cases.primeclerk.com/Synergy.

The agreement with Bausch Health comprises the initial stalking horse bid in the Court-supervised auction process. Bausch Health develops, manufactures and markets pharmaceutical, medical device and over-the-counter products across gastroenterology, eye health and dermatology areas. As previously announced, in December 2018, Synergy filed a voluntary petition for reorganization under Chapter 11 with the U.S. Bankruptcy Court for the Southern District of New York. Bausch Health Companies announced that the company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals for a cash purchase price of approximately $195 million and the assumption of certain assumed liabilities. from 8 AM - 9 PM ET, Copyright © 2020 PR Newswire Association LLC. We use cookies to ensure that we give you the best experience on our website. US election: where do the candidates stand on non-Covid healthcare issues. At that time, Bausch Health entered into a definitive agreement to acquire certain assets of Synergy. This financing, combined with existing cash on its balance sheet and normal operating cash flows, will allow Synergy to operate its business as usual and help fund its ongoing financial commitments while it works to complete the sale. NEW YORK, Dec. 12, 2018 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the "Company" or "Synergy"), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced an agreement with Bausch Health Companies Inc., through which Bausch Health would acquire substantially all of Synergy's assets, including all rights to TRULANCE® (plecanatide), dolcanatide and related intellectual property, for approximately $200 million in cash, subject to certain adjustments at closing, plus the assumption of certain liabilities related to the assets to be acquired. Bausch Health chairman and CEO Joseph Papa said: “We are excited to acquire the assets of Synergy, which we believe will strategically enhance our Salix Pharmaceuticals business and supplement our organic growth in gastroenterology. "We have worked diligently to serve our patients, health care professionals and other stakeholders by bringing TRULANCE® to market and developing other GI therapies to address previously unmet needs. Its investigational incremental peptide dolcanatide will also be added to Bausch Health’s pipeline.

“With our team’s expertise in GI and primary care, we will strengthen our already formidable portfolio of innovative irritable bowel syndrome solutions with the addition of Trulance. R&D, Production, Contract Manufacturing, and Marketing of Pharmaceutical Drugs, Automated Test Solutions for Pharmaceutical Drug Delivery Systems, Raw Material Handling and Containment Solutions for the Pharmaceutical Sector, 28 February 2019 (Last Updated February 28th, 2019 10:59). Important factors that may cause such differences include, but are not limited to, the decisions of the Court; negotiations with our debtholders,  our creditors and any committee approved by the Court;  negotiations with lenders on the definitive DIP financing documents; the Company's ability to meet the closing conditions of its DIP financing; the Company's ability to meet the requirements, and compliance with the terms, including restrictive covenants, of their respective DIP financing arrangements and any other financial arrangement while in Chapter 11 proceedings; changes in our operational or cash needs from the assumptions underlying our DIP budgets and forecasts; changes in our cash needs as compared to our historical operations or our planned reductions in operating expense; adverse litigation; changes in domestic and international demand for TRULANCE; our ability to control operating costs and other expenses; that general economic conditions may be worse than expected; that competition may increase significantly; changes in laws or government regulations or policies affecting our current business operations and, as well as those risks and uncertainties disclosed under the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Forms 10-Q filed with the Securities and Exchange Commission ("SEC") on May 10, 2018, August 8, 2018 and November 9, 2018 and Form 10-K filed with the SEC on March 1, 2018, and similar disclosures in subsequent reports filed with the SEC. Forward-looking statements discuss, among other matters: our financial and operational results, as well as our expectations for future financial trends and performance of our business in future periods; our strategy; risks and uncertainties associated with Chapter 11 proceedings; the negative impacts on our businesses as a result of filing for and operating under Chapter 11 protection; the time, terms and ability to confirm a Chapter 11 plan of reorganization for our businesses; the adequacy of the capital resources of our businesses and the difficulty in forecasting the liquidity requirements of the operations of our businesses; the unpredictability of our financial results while in Chapter 11 proceedings; our ability to discharge claims in Chapter 11 proceedings; negotiations with the holders of our indebtedness and our trade creditors; risks and uncertainties with performing under the terms of the debtor-in-possession ("DIP") financing arrangements and any other arrangement with lenders or creditors while in Chapter 11 proceedings; the Company's ability to operate our businesses within the terms of our respective DIP financing arrangements;  the forecasted uses of funds in the Company's  DIP budgets;  our  ability to conduct business as usual in the United States and worldwide; our ability to continue to serve customers, suppliers and other business partners at the high level of service and performance they have come to expect from us; our ability to continue to pay suppliers and vendors;  our ability to fund ongoing business operations through the applicable DIP financing arrangements; the use of the funds anticipated to be received in the DIP financing arrangements;  the ability to control costs during Chapter 11 proceedings; the risk that our Chapter 11 Cases may be converted to cases under Chapter 7 of the Bankruptcy Code; the ability of the Company to preserve and utilize the NOLs following Chapter 11 proceedings; the Company's ability to secure operating capital; the Company's ability to take advantage of opportunities to acquire assets with upside potential; the Company's ability to execute on its strategic plan to evaluate and close potential M&A opportunities; our long-term outlook; our preparation for future market conditions; and any statements or assumptions underlying any of the foregoing.



The Haunting Of Sharon Tate True, Mike Birbiglia Pronunciation, Chorizo Corn Chowder, Mae Name Meaning In Korean, Natural Pearl Necklace, Oleanna Meaning Of Name, Disney Apps Games, Microsoft Keyboard Not Working On Mac, Walpole, Ma Events Calendar, Just Want To Praise You Brooklyn Tabernacle Choir Lyrics, Bobbi Brown Eyeshadow Palette 2019, Irish Surnames And Meanings, International Boxing Federation Rules, El Delfin Verde Reviews, Police Task Force Acronyms, Jayda Ayanna Net Worth, Gorn Psvr, Science World Videos, Carson Daly Net Worth, The Toy Box Ending, Cheap Bachelor Degree In Uae, Wireless Keyboard And Mouse, Dr Ali Abbasi, Why Fireworks Tonight In Uk, Bane Venom, Love Monster And The Perfect Present, Who Sings Outlander Theme Song, How Old Is Dee Hartford, Vector 2 Garmin, What Is A Non Game Animal, Juan Of The Dead English Subtitles, Nfl 2k2 Dreamcast Rom, The Grass Is Greener Lyrics Pink Floyd, Overlord Trailer, Final Fantasy Chronicles, Stephen Dix Jr Fsu, 3d Printing San Francisco, Wire Haired Dachshund, Vagsoy Norway, Where Do I Begin L Word, Malaysia Weather In October, Window Tint, Sydney Conservatorium Of Music Handbook, Seattle Weather In February 2020, Ramiel Dragalia, Bobby Moore Academy Headteacher, List Of Video Game Consoles, Goliath Height, Princess Morbucks Voice, All Day, All Night Wtf Lyrics, Fireworks Edmonton Tonight, Ielts Speaking Friends Part 3, Jack Dempsey Siblings, Man Utd Players Wages, Annette Charles Age, Does Barrier Block Ignite, 2009 Miami Dolphins Roster, Barry Jhay Ise Oluwa Lyrics, Roger L Jackson Net Worth, Neverending Story Netflix, Elephant Cartoon Movie List, Are Tums Safe To Take Everyday, How Does Congress Get Paid, Is The Clark County Fair Cancelled 2020, Cancer Flower, Chaka Khan Through The Fire Acapella, Meteora Butterfly, Susie Carmichael | Nopixel, Chromoprotein Ppt, Olympics 1956, Guitarist Phonetic Transcription, Nightlife In Singapore, Lily Weatherford Obituary, Pharmaceutical Raw Material Companies In Pakistan, Text-decoration-color Not Working, Noun And Verb Words Example With Sentences, Grit: The Power Of Passion And Perseverance Pdf, Team Synergy Esports, Qpu Meaning Mario, If You May In A Sentence,